Ibutilide, a methanesulfonanilide antiarrhythmic, is a potent blocker of the rapidly activating delayed rectifier K+ current (IKr) in AT-1 cells. Concentration-, time-, voltage-, and use-dependent effects.

BACKGROUND Ibutilide is an action potential-prolonging antiarrhythmic currently in clinical trials. The drug shares structural similarities with E-4031 and dofetilide, specific blockers of the rapidly activating delayed rectifier K+ current (IKr). However, previous in vitro studies in guinea pig myocytes have indicated that ibutilide does not block IKr but rather increases a slow inward sodium current. METHODS AND RESULTS In this study, we compared the effects of ibutilide with those of dofetilide on outward current in mouse atrial tumor myocytes (AT-1 cells), a preparation in which, unlike guinea pig, a typical IKr is the major delayed rectifier and can be readily recorded in isolation from other currents. In AT-1 cells, ibutilide and dofetilide were both potent IKr blockers, with EC50 values of 20 (n = 12) and 12 (n = 8) nmol/L, respectively, at +20 mV. The time and voltage dependence of IKr inhibition by the two compounds were virtually identical. The following characteristics were most consistent with open channel block: (1) block increased with depolarizing pulses; (2) block increased with longer pulses; (3) currents deactivated more slowly in the presence of drug, resulting in a "crossover" typical of open channel block; and (4) with repetitive pulsing after drug wash-in, use-dependent block was observed. CONCLUSIONS These data suggest that the clinical actions of ibutilide are mediated at least in part by block of IKr; an effect on inward currents is not excluded. AT-1 cells are a useful model system for the study of drug block of this important repolarizing current.

[1]  K. Murray,et al.  A Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Ranging Study of Dofetilide in Patients with Inducible Sustained Ventricular Tachyarrhythmias , 1995, Journal of cardiovascular electrophysiology.

[2]  D. Roden,et al.  K+ currents and K+ channel mRNA in cultured atrial cardiac myocytes (AT-1 cells). , 1994, Circulation research.

[3]  B. Singh,et al.  Arrhythmia control by prolonging repolarization: the concept and its potential therapeutic impact. , 1993, European heart journal.

[4]  J. K. Gibson,et al.  Comparative Assessment of Ibutilide, D‐Sotalol, Clofilium, E‐4031, and UK‐68, 798 in a Rabbit Model of Proarrhythmia , 1993, Journal of cardiovascular pharmacology.

[5]  H. Crijns,et al.  Torsades de pointes with Almokalant, a new class III antiarrhythmic drug. , 1993, American heart journal.

[6]  D. Roden.  Current status of class III antiarrhythmic drug therapy. , 1993, The American journal of cardiology.

[7]  M C Sanguinetti,et al.  Cardiac electrophysiologic and antiarrhythmic actions of 3,4-dihydro-1'-[2-(benzofurazan-5-yl) ethyl]-6-methanesulfonamidospiro [(2H)-1-benzopyran-2,4'-piperidin]-4-one HCl (L-691,121), a novel class III agent. , 1993, The Journal of pharmacology and experimental therapeutics.

[8]  R. Wesley,et al.  Ibutilide: enhanced defibrillation via plateau sodium current activation. , 1993, The American journal of physiology.

[9]  K. S. Lee,et al.  Membrane activity of class III antiarrhythmic compounds; a comparison between ibutilide, d-sotalol, E-4031, sematilide and dofetilide. , 1993, European journal of pharmacology.

[10]  M. Sanguinetti,et al.  Rate-dependent prolongation of cardiac action potentials by a methanesulfonanilide class III antiarrhythmic agent. Specific block of rapidly activating delayed rectifier K+ current by dofetilide. , 1993, Circulation research.

[11]  J. K. Gibson,et al.  Effects of ibutilide fumarate, a novel antiarrhythmic agent, and its enantiomers on isolated rabbit myocardium. , 1992, European journal of pharmacology.

[12]  E. Carmeliet.  Voltage- and time-dependent block of the delayed K+ current in cardiac myocytes by dofetilide. , 1992, The Journal of pharmacology and experimental therapeutics.

[13]  K. S. Lee.  Ibutilide, a new compound with potent class III antiarrhythmic activity, activates a slow inward Na+ current in guinea pig ventricular cells. , 1992, The Journal of pharmacology and experimental therapeutics.

[14]  S. Roberds,et al.  Time-, voltage-, and state-dependent block by quinidine of a cloned human cardiac potassium channel. , 1992, Molecular pharmacology.

[15]  D. Roden,et al.  Pharmacology of the class III antiarrhythmic agent sematilide in patients with arrhythmias. , 1992, The American journal of cardiology.

[16]  W. Claycomb,et al.  Morphological characterization of cardiomyocytes isolated from a transplantable cardiac tumor derived from transgenic mouse atria (AT-1 cells). , 1991, Circulation research.

[17]  D. Roden,et al.  Suppression of time-dependent outward current in guinea pig ventricular myocytes. Actions of quinidine and amiodarone. , 1991, Circulation research.

[18]  J. Dimarco.  Cardioversion of atrial flutter by intravenous ibutilide, a new class III antiarrhythmic agent , 1991 .

[19]  M. Sanguinetti,et al.  Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes. Mechanism of action. , 1991, Circulation research.

[20]  W. Claycomb,et al.  Proliferation in vivo and in culture of differentiated adult atrial cardiomyocytes from transgenic mice. , 1990, The American journal of physiology.

[21]  M. Sanguinetti,et al.  Lanthanum blocks a specific component of IK and screens membrane surface change in cardiac cells. , 1990, The American journal of physiology.

[22]  T. Colatsky,et al.  Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias. , 1990, Circulation.

[23]  D. Roden,et al.  Time-dependent outward current in guinea pig ventricular myocytes. Gating kinetics of the delayed rectifier , 1990, The Journal of general physiology.

[24]  L. Chi,et al.  Antiarrhythmic and Electrophysiologic Actions of CK‐357 and Sematilide in a Conscious Canine Model of Sudden Coronary Death , 1990, Journal of cardiovascular pharmacology.

[25]  T. Colatsky,et al.  Block of delayed rectifier potassium current, IK, by flecainide and E-4031 in cat ventricular myocytes. , 1990, Circulation.

[26]  M. Sanguinetti,et al.  Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents , 1990, The Journal of general physiology.

[27]  R. Harvey,et al.  Autonomic regulation of a chloride current in heart. , 1989, Science.

[28]  D. Echt,et al.  Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation. , 1989, Circulation.

[29]  L. Field,et al.  Atrial natriuretic factor-SV40 T antigen transgenes produce tumors and cardiac arrhythmias in mice. , 1988, Science.

[30]  T. Shibasaki,et al.  Conductance and kinetics of delayed rectifier potassium channels in nodal cells of the rabbit heart. , 1987, The Journal of physiology.

[31]  W. Kou,et al.  Effect of flecainide acetate on prevention of electrical induction of ventricular tachycardia and occurrence of ischemic ventricular fibrillation during the early postmyocardial infarction period: evaluation in a conscious canine model of sudden death. , 1987, Journal of the American College of Cardiology.

[32]  E. Carmeliet.  Electrophysiologic and voltage clamp analysis of the effects of sotalol on isolated cardiac muscle and Purkinje fibers. , 1985, The Journal of pharmacology and experimental therapeutics.